If you made any changes in Pure these will be visible here soon.

Research Output

2019

Characterization of patients with metastatic non-small-cell lung cancer obtaining long-term benefit from immunotherapy

Galli, G., Proto, C., Signorelli, D., Imbimbo, M., Ferrara, R., Prelaj, A., De Toma, A., Ganzinelli, M., Zilembo, N., De Braud, F., Garassino, M. C. & Lo Russo, G., Aug 2019, In : Future Oncology. 15, 23, p. 2743-2757 15 p.

Research output: Contribution to journalArticle

Choosing wisely first line immunotherapy in non-small cell lung cancer (NSCLC): what to add and what to leave out

Proto, C., Ferrara, R., Signorelli, D., Lo Russo, G., Galli, G., Imbimbo, M., Prelaj, A., Zilembo, N., Ganzinelli, M., Pallavicini, L. M., De Simone, I., Colombo, M. P., Sica, A., Torri, V. & Garassino, M. C., May 2019, In : Cancer Treatment Reviews. 75, p. 39-51 13 p.

Research output: Contribution to journalArticle

Choosing wisely first line immunotherapy in non-small cell lung cancer (NSCLC): what to add and what to leave out

Proto, C., Ferrara, R., Signorelli, D., Lo Russo, G., Galli, G., Imbimbo, M., Prelaj, A., Zilembo, N., Ganzinelli, M., Pallavicini, L. M., De Simone, I., Colombo, M. P., Sica, A., Torri, V. & Garassino, M. C., May 2019, In : Cancer Treatment Reviews. 75, p. 39-51 13 p.

Research output: Contribution to journalReview article

Efficacy and safety of immunotherapy in elderly patients with non-small cell lung cancer

Galli, G., De Toma, A., Pagani, F., Randon, G., Trevisan, B., Prelaj, A., Ferrara, R., Proto, C., Signorelli, D., Ganzinelli, M., Zilembo, N., de Braud, F., Garassino, M. C. & Lo Russo, G., Nov 2019, In : Lung Cancer. 137, p. 38-42 5 p.

Research output: Contribution to journalArticle

Epsilon: A prognostic score for immunotherapy in advanced non-small-cell lung cancer: A validation cohort

Prelaj, A., Ferrara, R., Rebuzzi, S. E., Proto, C., Signorelli, D., Galli, G., De Toma, A., Randon, G., Pagani, F., Viscardi, G., Brambilla, M., Trevisan, B., Ganzinelli, M., Martinetti, A., Gallucci, R., Di Mauro, R. M., Molino, G., Zilembo, N., Torri, V., de Braud, F. M. & 2 others, Garassino, M. C. & Lo Russo, G., Dec 2019, In : Cancers. 11, 12, 1954.

Research output: Contribution to journalArticle

Open Access

Lung Cancer App (LuCApp) study protocol: A randomised controlled trial to evaluate a mobile supportive care app for patients with metastatic lung cancer

Ciani, O., Cucciniello, M., Petracca, F., Apolone, G., Merlini, G., Novello, S., Pedrazzoli, P., Zilembo, N., Broglia, C., Capelletto, E., Garassino, M., Nicod, E. & Tarricone, R., Feb 1 2019, In : BMJ Open. 9, 2, e025483.

Research output: Contribution to journalArticle

Lung Cancer App (LuCApp) study protocol: A randomised controlled trial to evaluate a mobile supportive care app for patients with metastatic lung cancer

Ciani, O., Cucciniello, M., Petracca, F., Apolone, G., Merlini, G., Novello, S., Pedrazzoli, P., Zilembo, N., Broglia, C., Capelletto, E., Garassino, M., Nicod, E. & Tarricone, R., 2019, In : BMJ Open. 9, 2

Research output: Contribution to journalArticle

2018

Low Baseline Serum Sodium Concentration Is Associated with Poor Clinical Outcomes in Metastatic Non-Small Cell Lung Cancer Patients Treated with Immunotherapy

Fucà, G., Galli, G., Poggi, M., Lo Russo, G., Proto, C., Imbimbo, M., Vitali, M., Ganzinelli, M., Lanti, C., Molino, G., Stangoni, F., Zilembo, N., de Braud, F., Garassino, M. C. & Signorelli, D., Dec 2018, In : Targeted Oncology. 13, 6, p. 795-800 6 p.

Research output: Contribution to journalArticle

Outcomes of First-Generation EGFR-TKIs Against Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Post Hoc Analysis of the BE-POSITIVE Study

Pilotto, S., Rossi, A., Vavalà, T., Follador, A., Tiseo, M., Galetta, D., Morabito, A., Di Maio, M., Martelli, O., Caffo, O., Piovano, P. L., Cortinovis, D., Zilembo, N., Casartelli, C., Banna, G. L., Ardizzoia, A., Barzelloni, M. L., Bearz, A., Genestreti, G., Mucciarini, C. & 9 others, Filipazzi, V., Menis, J., Rizzo, E., Barbieri, F., Rijavec, E., Cecere, F., Spitaleri, G., Bria, E. & Novello, S., Jan 2018, In : Clinical Lung Cancer. 19, 1, p. 93-104 12 p.

Research output: Contribution to journalArticle

Outcomes of First-Generation EGFR-TKIs Against Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Post Hoc Analysis of the BE-POSITIVE Study

Pilotto, S., Rossi, A., Vavalà, T., Follador, A., Tiseo, M., Galetta, D., Morabito, A., Di Maio, M., Martelli, O., Caffo, O., Piovano, P. L., Cortinovis, D., Zilembo, N., Casartelli, C., Banna, G. L., Ardizzoia, A., Barzelloni, M. L., Bearz, A., Genestreti, G., Mucciarini, C. & 9 others, Filipazzi, V., Menis, J., Rizzo, E., Barbieri, F., Rijavec, E., Cecere, F., Spitaleri, G., Bria, E. & Novello, S., Jan 2018, In : Clinical Lung Cancer. 19, 1, p. 93-104 12 p.

Research output: Contribution to journalArticle

Outcomes of First-Generation EGFR-TKIs Against Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Post Hoc Analysis of the BE-POSITIVE Study

Pilotto, S., Rossi, A., Vavalà, T., Follador, A., Tiseo, M., Galetta, D., Morabito, A., Di Maio, M., Martelli, O., Caffo, O., Piovano, P. L., Cortinovis, D., Zilembo, N., Casartelli, C., Banna, G. L., Ardizzoia, A., Barzelloni, M. L., Bearz, A., Genestreti, G., Mucciarini, C. & 9 others, Filipazzi, V., Menis, J., Rizzo, E., Barbieri, F., Rijavec, E., Cecere, F., Spitaleri, G., Bria, E. & Novello, S., 2018, In : Clinical Lung Cancer. 19, 1, p. 93-104 12 p.

Research output: Contribution to journalArticle

Practical issues for the management of hyponatremia in oncology

Berardi, R., Antonuzzo, A., Blasi, L., Buosi, R., Lorusso, V., Migliorino, M. R., Montesarchio, V., Zilembo, N., Sabbatini, R. & Peri, A., Feb 7 2018, (Accepted/In press) In : Endocrine. 61, 1, p. 158-164 7 p.

Research output: Contribution to journalArticle

Practical issues for the management of hyponatremia in oncology

Berardi, R., Antonuzzo, A., Blasi, L., Buosi, R., Lorusso, V., Migliorino, M. R., Montesarchio, V., Zilembo, N., Sabbatini, R. & Peri, A., Jul 2018, In : Endocrine. 61, 1, p. 158-164 7 p.

Research output: Contribution to journalReview article

Uncommon mutations in epidermal growth factor receptor and response to first and second generation tyrosine kinase inhibitors: A case series and literature review

Galli, G., Corrao, G., Imbimbo, M., Proto, C., Signorelli, D., Ganzinelli, M., Zilembo, N., Vitali, M., de Braud, F., Garassino, M. C. & Lo Russo, G., 2018, In : Lung Cancer. 115, p. 135-142 8 p.

Research output: Contribution to journalArticle

2017

Concomitant EML4-ALK rearrangement and EGFR mutation in non-small cell lung cancer patients: A literature review of 100 cases

Russo, G. L., Imbimbo, M., Corrao, G., Proto, C., Signorelli, D., Vitali, M., Ganzinelli, M., Botta, L., Zilembo, N., de Braud, F. & Garassino, M. C., Jan 1 2017, In : Oncotarget. 8, 35, p. 59889-59900 12 p.

Research output: Contribution to journalReview article

Italian, multicenter, phase III, randomized study of cisplatin plus etoposide with or without bevacizumab as first-line treatment in extensive-disease small-cell lung cancer: The GOIRC-AIFA FARM6PMFJM trial

Tiseo, M., Boni, L., Ambrosio, F., Camerini, A., Baldini, E., Cinieri, S., Brighenti, M., Zanelli, F., Defraia, E., Chiari, R., Dazzi, C., Tibaldi, C., Turolla, G. M., D'Alessandro, V., Zilembo, N., Trolese, A. R., Grossi, F., Riccardi, F. & Ardizzoni, A., Apr 20 2017, In : Journal of Clinical Oncology. 35, 12, p. 1281-1287 7 p.

Research output: Contribution to journalArticle

Italian, Multicenter, Phase III, Randomized Study of Cisplatin Plus Etoposide With or Without Bevacizumab as First-Line Treatment in Extensive-Disease Small-Cell Lung Cancer: The GOIRC-AIFA FARM6PMFJM Trial

Tiseo, M., Boni, L., Ambrosio, F., Camerini, A., Baldini, E., Cinieri, S., Brighenti, M., Zanelli, F., Defraia, E., Chiari, R., Dazzi, C., Tibaldi, C., Turolla, G. M., D'Alessandro, V., Zilembo, N., Trolese, A. R., Grossi, F., Riccardi, F. & Ardizzoni, A., Apr 20 2017, In : Journal of Clinical Oncology. 35, 12, p. 1281-1287 7 p.

Research output: Contribution to journalArticle

Italian, Multicenter, Phase III, Randomized Study of Cisplatin Plus Etoposide With or Without Bevacizumab as First-Line Treatment in Extensive-Disease Small-Cell Lung Cancer: The GOIRC-AIFA FARM6PMFJM Trial

Tiseo, M., Boni, L., Ambrosio, F., Camerini, A., Baldini, E., Cinieri, S., Brighenti, M., Zanelli, F., Defraia, E., Chiari, R., Dazzi, C., Tibaldi, C., Turolla, G. M., D’Alessandro, V., Zilembo, N., Trolese, A. R., Grossi, F., Riccardi, F. & Ardizzoni, A., Jan 30 2017, In : Journal of Clinical Oncology. 35, 12, p. 1281-1287 7 p.

Research output: Contribution to journalArticle

Outcomes of First-Generation EGFR-TKIs Against Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Post Hoc Analysis of the BE-POSITIVE Study

Pilotto, S., Rossi, A., Vavalà, T., Follador, A., Tiseo, M., Galetta, D., Morabito, A., Di Maio, M., Martelli, O., Caffo, O., Piovano, P. L., Cortinovis, D., Zilembo, N., Casartelli, C., Banna, G. L., Ardizzoia, A., Barzelloni, M. L., Bearz, A., Genestreti, G., Mucciarini, C. & 9 others, Filipazzi, V., Menis, J., Rizzo, E., Barbieri, F., Rijavec, E., Cecere, F., Spitaleri, G., Bria, E. & Novello, S., 2017, In : Clinical Lung Cancer.

Research output: Contribution to journalArticle

Small-cell lung cancer: Clinical management and unmet needs new perspectives for an old problem

Russo, G. L., Macerelli, M., Platania, M., Zilembo, N., Vitali, M., Signorelli, D., Proto, C., Ganzinelli, M., Gallucci, R., Agustoni, F., Fasola, G., de Braud, F. & Garassino, M. C., Mar 1 2017, In : Current Drug Targets. 18, 3, p. 341-362 22 p.

Research output: Contribution to journalReview article

2016

BE-POSITIVE: Beyond progression after tyrosine kinase inhibitor in EGFR- positive non small cell lung cancer patients. Results from a multicenter Italian observational study.

Vavalà, T., Follador, A., Tiseo, M., Galetta, D., Morabito, A., Di Maio, M., Martelli, O., Caffo, O., Piovano, P. L., Cortinovis, D. L., Zilembo, N., Casartelli, C., Banna, G. L., Ardizzoia, A., Barzelloni, M. L., Bearz, A., Genestreti, G., Mucciarini, C., Filipazzi, V., Menis, J. & 8 others, Rizzo, E., Barbieri, F., Rijavec, E., Cecere, F., Bria, E., Spitaleri, G., Rossi, A. & Novello, S., May 1 2016, In : Lung Cancer. 95, p. 73-81 9 p.

Research output: Contribution to journalArticle

BE-POSITIVE: Beyond progression after tyrosine kinase inhibitor in EGFR- positive non small cell lung cancer patients. Results from a multicenter Italian observational study.

Vavalà, T., Follador, A., Tiseo, M., Galetta, D., Morabito, A., Di Maio, M., Martelli, O., Caffo, O., Piovano, P. L., Cortinovis, D. L., Zilembo, N., Casartelli, C., Banna, G. L., Ardizzoia, A., Barzelloni, M. L., Bearz, A., Genestreti, G., Mucciarini, C., Filipazzi, V., Menis, J. & 8 others, Rizzo, E., Barbieri, F., Rijavec, E., Cecere, F., Bria, E., Spitaleri, G., Rossi, A. & Novello, S., May 1 2016, In : Lung Cancer. 95, p. 73-81 9 p.

Research output: Contribution to journalArticle

BE-POSITIVE: Beyond progression after tyrosine kinase inhibitor in EGFR- positive non small cell lung cancer patients. Results from a multicenter Italian observational study.

Vavalà, T., Follador, A., Tiseo, M., Galetta, D., Morabito, A., Di Maio, M., Martelli, O., Caffo, O., Piovano, P. L., Cortinovis, D. L., Zilembo, N., Casartelli, C., Banna, G. L., Ardizzoia, A., Barzelloni, M. L., Bearz, A., Genestreti, G., Mucciarini, C., Filipazzi, V., Menis, J. & 8 others, Rizzo, E., Barbieri, F., Rijavec, E., Cecere, F., Bria, E., Spitaleri, G., Rossi, A. & Novello, S., May 1 2016, In : Lung Cancer. 95, p. 73-81 9 p.

Research output: Contribution to journalArticle

BE-POSITIVE: Beyond progression after tyrosine kinase inhibitor in EGFR- positive non small cell lung cancer patients. Results from a multicenter Italian observational study.

Vavalà, T., Follador, A., Tiseo, M., Galetta, D., Morabito, A., Di Maio, M., Martelli, O., Caffo, O., Piovano, P. L., Cortinovis, D. L., Zilembo, N., Casartelli, C., Banna, G. L., Ardizzoia, A., Barzelloni, M. L., Bearz, A., Genestreti, G., Mucciarini, C., Filipazzi, V., Menis, J. & 8 others, Rizzo, E., Barbieri, F., Rijavec, E., Cecere, F., Bria, E., Spitaleri, G., Rossi, A. & Novello, S., May 1 2016, In : Lung Cancer. 95, p. 73-81 9 p.

Research output: Contribution to journalArticle

BE-POSITIVE: Beyond progression after tyrosine kinase inhibitor in EGFR- positive non small cell lung cancer patients. Results from a multicenter Italian observational study.

Vavalà, T., Follador, A., Tiseo, M., Galetta, D., Morabito, A., Di Maio, M., Martelli, O., Caffo, O., Piovano, P. L., Cortinovis, D. L., Zilembo, N., Casartelli, C., Banna, G. L., Ardizzoia, A., Barzelloni, M. L., Bearz, A., Genestreti, G., Mucciarini, C., Filipazzi, V., Menis, J. & 8 others, Rizzo, E., Barbieri, F., Rijavec, E., Cecere, F., Bria, E., Spitaleri, G., Rossi, A. & Novello, S., May 1 2016, In : Lung Cancer. 95, p. 73-81 9 p.

Research output: Contribution to journalArticle

BE-POSITIVE: Beyond progression after tyrosine kinase inhibitor in EGFR- positive non small cell lung cancer patients. Results from a multicenter Italian observational study.

Vavalà, T., Follador, A., Tiseo, M., Galetta, D., Morabito, A., Di Maio, M., Martelli, O., Caffo, O., Piovano, P. L., Cortinovis, D., Zilembo, N., Casartelli, C., Banna, G. L., Ardizzoia, A., Barzelloni, M. L., Bearz, A., Genestreti, G., Mucciarini, C., Filipazzi, V., Menis, J. & 8 others, Rizzo, E., Barbieri, F., Rijavec, E., Cecere, F., Bria, E., Spitaleri, G., Rossi, A. & Novello, S., May 1 2016, In : Lung Cancer. 95, p. 73-81 9 p.

Research output: Contribution to journalArticle

Systemic approach to malignant pleural mesothelioma: What news of chemotherapy, targeted agents and immunotherapy?

Signorelli, D., Macerelli, M., Proto, C., Vitali, M., Cona, M. S., Agustoni, F., Zilembo, N., Platania, M., Trama, A., Gallucci, R., Ganzinelli, M., Pelosi, G., Pastorino, U., De Braud, F., Garassino, M. C. & Lo Russo, G., Jan 1 2016, In : Tumori. 102, 1, p. 18-30 13 p.

Research output: Contribution to journalArticle

Treatment of lung large cell neuroendocrine carcinoma

Lo Russo, G., Pusceddu, S., Proto, C., Macerelli, M., Signorelli, D., Vitali, M., Ganzinelli, M., Gallucci, R., Zilembo, N., Platania, M., Buzzoni, R., de Braud, F. & Garassino, M. C., Mar 4 2016, (Accepted/In press) In : Tumor Biology. p. 1-11 11 p.

Research output: Contribution to journalArticle

2015

Italian multicenter phase III randomized study of cisplatin-etoposide with or without bevacizumab as first-line treatment in extensive stage small cell lung cancer: Treatment rationale and protocol design of the GOIRC-AIFA FARM6PMFJM trial

Tiseo, M., Boni, L., Ambrosio, F., Camerini, A., Vitale, M. G., Baldini, E., Cinieri, S., Zanelli, F., Defraia, E., Passalacqua, R., Crino, L., Dazzi, C., Tibaldi, C., Turolla, G. M., D'Alessandro, V., Zilembo, N., Riccardi, F. & Ardizzoni, A., Jan 1 2015, In : Clinical Lung Cancer. 16, 1, p. 67-70 4 p.

Research output: Contribution to journalArticle

2014

A prospective observational study to evaluate G-CSF usage in patients with solid tumors receiving myelosuppressive chemotherapy in Italian clinical oncology practice

Barni, S., Lorusso, V., Giordano, M., Sogno, G., Gamucci, T., Santoro, A., Passalacqua, R., Iaffaioli, V., Zilembo, N., Mencoboni, M., Roselli, M., Pappagallo, G. & Pronzato, P., 2014, In : Medical Oncology. 31, 1, 797.

Research output: Contribution to journalArticle

Emerging toxicities in the treatment of non-small cell lung cancer: Ocular disorders

Agustoni, F., Platania, M., Vitali, M., Zilembo, N., Haspinger, E., Sinno, V., Gallucci, R., De Braud, F. & Garassino, M. C., Feb 2014, In : Cancer Treatment Reviews. 40, 1, p. 197-203 7 p.

Research output: Contribution to journalArticle

Phase II randomized study of vandetanib plus gemcitabine or gemcitabine plus placebo as first-line treatment of advanced non-small-cell lung cancer in elderly patients

Gridelli, C., Novello, S., Zilembo, N., Luciani, A., Favaretto, A. G., De Marinis, F., Genestreti, G., Crinò, L., Grossi, F., Caffo, O., Ferraù, F., Cruciani, G., Brandes, A. A., Galetta, D., Barni, S., Fasola, G., Cerea, G., Ferrari, S., Iannacone, C. & Ciardiello, F., 2014, In : Journal of Thoracic Oncology. 9, 5, p. 733-737 5 p.

Research output: Contribution to journalArticle

Targeted therapy-induced diarrhea: A review of the literature

Pessi, M. A., Zilembo, N., Haspinger, E. R., Molino, L., Di Cosimo, S., Garassino, M. & Ripamonti, C. I., 2014, In : Critical Reviews in Oncology/Hematology. 90, 2, p. 165-179 15 p.

Research output: Contribution to journalArticle

2013

Overall survival for sorafenib plus interleukin-2 compared with sorafenib alone in metastatic renal cell carcinoma (mRCC): Final results of the ROSORC trial

Procopio, G., Verzoni, E., Bracarda, S., Ricci, S., Sacco, C., Ridolfi, L., Porta, C., Miceli, R., Zilembo, N. & Bajetta, E., Dec 2013, In : Annals of Oncology. 24, 12, p. 2967-2971 5 p., mdt375.

Research output: Contribution to journalArticle

Phase II study of pemetrexed and carboplatin plus bevacizumab as first-line therapy in malignant pleural mesothelioma

Ceresoli, G. L., Zucali, P. A., Mencoboni, M., Botta, M., Grossi, F., Cortinovis, D., Zilembo, N., Ripa, C., Tiseo, M., Favaretto, A. G., Soto-Parra, H., De Vincenzo, F., Bruzzone, A., Lorenzi, E., Gianoncelli, L., Ercoli, B., Giordano, L. & Santoro, A., Aug 6 2013, In : British Journal of Cancer. 109, 3, p. 552-558 7 p.

Research output: Contribution to journalArticle

2012

Pemetrexed versus pemetrexed and carboplatin as second-line chemotherapy in advanced non-small-cell lung cancer: Results of the GOIRC 02-2006 randomized phase II study and pooled analysis with the NVALT7 trial

Ardizzoni, A., Tiseo, M., Boni, L., Vincent, A. D., Passalacqua, R., Buti, S., Amoroso, D., Camerini, A., Labianca, R., Genestreti, G., Boni, C., Ciuffreda, L., Di Costanzo, F., De Marinis, F., Crinò, L., Santo, A., Pazzola, A., Barbieri, F., Zilembo, N., Colantonio, I. & 5 others, Tibaldi, C., Mattioli, R., Cafferata, M. A., Camisa, R. & Smit, E. F., Dec 20 2012, In : Journal of Clinical Oncology. 30, 36, p. 4501-4507 7 p.

Research output: Contribution to journalArticle

2011

Clinical retrospective analysis of erlotinib in the treatment of elderly patients with advanced non-small cell lung cancer

Platania, M., Agustoni, F., Formisano, B., Vitali, M., Ducceschi, M., Pietrantonio, F., Zilembo, N., Gelsomino, F., Pusceddu, S. & Buzzoni, R., Sep 2011, In : Targeted Oncology. 6, 3, p. 181-186 6 p.

Research output: Contribution to journalArticle

Medical treatment choices for patients affected by advanced NSCLC in routine clinical practice: Results from the Italian observational "SUN" (Survey on the lUng cancer maNagement) study

Gridelli, C., Ardizzoni, A., Barni, S., Crinò, L., Caprioli, A., Piazza, E., Lorusso, V., Barbera, S., Zilembo, N., Gebbia, V., Adamo, V., Pela, R., Marangolo, M., Morena, R., Filippelli, G., Buscarino, C., Alabiso, O., Maione, P., Venturino, P. & De Marinis, F., Dec 2011, In : Lung Cancer. 74, 3, p. 462-468 7 p.

Research output: Contribution to journalArticle

Neuroendocrine tumors of unknown primary site: Gold dust or misdiagnosed neoplasms?

Catena, L., Bichisao, E., Milione, M., Valente, M., Platania, M., Pusceddu, S., Ducceschi, M., Zilembo, N., Formisano, B. & Bajetta, E., Sep 2011, In : Tumori. 97, 5, p. 564-567 4 p.

Research output: Contribution to journalArticle

Sorafenib with interleukin-2 vs sorafenib alone in metastatic renal cell carcinoma: The ROSORC trial

Procopio, G., Verzoni, E., Bracarda, S., Ricci, S., Sacco, C., Ridolfi, L., Porta, C., Miceli, R., Zilembo, N. & Bajetta, E., Apr 12 2011, In : British Journal of Cancer. 104, 8, p. 1256-1261 6 p.

Research output: Contribution to journalArticle

2010

An unusually large pleural mesothelioma with an outstanding clinical response and long lasting survival: A case report and literature review

Zilembo, N., Vitali, M., Pietrantonio, F., Platania, M., Del Vecchio, M. & Bajetta, E., Nov 2010, In : Tumori. 96, 6, p. 1031-1034 4 p.

Research output: Contribution to journalArticle

Phase II study of asparagine-glycine-arginine-human tumor necrosis factor α, a selective vascular targeting agent, in previously treated patients with malignant pleural mesothelioma

Gregorc, V., Zucali, P. A., Santoro, A., Ceresoli, G. L., Citterio, G., De Pas, T. M., Zilembo, N., De Vincenzo, F., Simonelli, M., Rossoni, G., Spreafico, A., Viganò, M. G., Fontana, F., De Braud, F. G., Bajetta, E., Caligaris-Cappio, F., Bruzzi, P., Lambiase, A. & Bordignon, C., May 20 2010, In : Journal of Clinical Oncology. 28, 15, p. 2604-2611 8 p.

Research output: Contribution to journalArticle

2008

Is irinotecan plus docetaxel useful as second-line therapy in advanced non-small cell lung cancer?

Cortinovis, D., Bidoli, P., Cullurà, D., Lorusso, V., Ardizzoia, A., Amoroso, V., Bandera, M., Aitini, E., Fusi, A., Zilembo, N., Radula, D. & Bajetta, E., Apr 2008, In : Journal of Thoracic Oncology. 3, 4, p. 405-411 7 p.

Research output: Contribution to journalArticle

Oxaliplatin doublets in non-small cell lung cancer: A literature review

Cortinovis, D., Bidoli, P., Zilembo, N., Fusi, A. & Bajetta, E., Jun 2008, In : Lung Cancer. 60, 3, p. 325-331 7 p.

Research output: Contribution to journalArticle

2007

Feasibility of sequential therapy with FOLFIRI followed by docetaxel/cisplatin in patients with radically resected gastric adenocarcinoma: A randomized phase III trial

Di Bartolomeo, M., Buzzoni, R., Mariani, L., Ferrario, E., Katia, D., Gevorgyan, A., Zilembo, N., Bordonaro, R., Bochicchio, A. M., Massidda, B., Ardizzoni, A., Marini, G., Aitini, E., Schieppati, G., Comella, G., Pinotti, G., Palazzo, S., Cicero, G. & Bajetta, E., Oct 2007, In : Oncology. 71, 5-6, p. 341-346 6 p.

Research output: Contribution to journalArticle

Randomized phase II three-arm trial with three platinum-based doublets in metastatic non-small-cell lung cancer. An Italian Trials in Medical Oncology study

Bidoli, P., Zilembo, N., Cortinovis, D., Mariani, L., Isa, L., Aitini, E., Cullurà, D., Pari, F., Nova, P., Mancin, M., Formisano, B. & Bajetta, E., Mar 2007, In : Annals of Oncology. 18, 3, p. 461-467 7 p.

Research output: Contribution to journalArticle

Uracil/ftorafur/leucovorin combined with irinotecan (TEGAFIRI) or oxaliplatin (TEGAFOX) as first-line treatment for metastatic colorectal cancer patients: Results of randomised phase II study

Bajetta, E., Di Bartolomeo, M., Buzzoni, R., Mariani, L., Zilembo, N., Ferrario, E., Lo Vullo, S., Aitini, E., Isa, L., Barone, C., Jacobelli, S., Recaldin, E., Pinotti, G. & Iop, A., Feb 12 2007, In : British Journal of Cancer. 96, 3, p. 439-444 6 p.

Research output: Contribution to journalArticle